Kannel William B, Vasan Ramachandran S, Keyes Michelle J, Sullivan Lisa M, Robins Sander J
The National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA.
Am J Cardiol. 2008 Feb 15;101(4):497-501. doi: 10.1016/j.amjcard.2007.09.109.
Increased triglycerides (TG) and decreased high-density lipoprotein (HDL) cholesterol are key metabolic abnormalities in patients with insulin resistance (IR) states, including diabetes mellitus. The TG/HDL cholesterol ratio was advocated as a simple clinical indicator of IR, but studies yielded inconsistent results. The total cholesterol/HDL cholesterol ratio was widely used to assess lipid atherogenesis, but its utility for assessing IR or its associated coronary heart disease (CHD) risk was unknown. TG/HDL cholesterol and total cholesterol/HDL cholesterol ratios were related to IR (top quartile of the homeostasis model assessment-IR) in 3,014 patients (mean age 54 years; 55% women). Logistic regression was used to construct receiver-operator characteristic curves for predicting IR, with lipid ratios as predictors. Multivariable Cox regression was used to evaluate whether adjusting for lipid ratios attenuated the association of IR with CHD. Cross sectionally, age- and gender-adjusted correlations of IR were 0.46 with TG/HDL cholesterol ratio and 0.38 with total/HDL cholesterol ratio. IR prevalence increased across tertiles of lipid ratios (p <0.0001). The area under the receiver-operator characteristic curves for predicting IR with TG/HDL cholesterol ratio was 0.745, slightly higher than that for total/HDL cholesterol ratio (0.707; p <0.001 for comparison). On follow-up (mean 6.4 years), 112 patients experienced initial CHD events. IR was associated with CHD risk (multivariable-adjusted hazards ratio 2.71, 95% confidence interval 1.79 to 4.11), which remained significant even after adjustment for lipid ratios. In conclusion, our observations suggested that the TG/HDL cholesterol ratio was an imperfect surrogate for IR and its associated CHD risk, and it was only slightly better than the total/HDL cholesterol ratio for this purpose.
甘油三酯(TG)升高和高密度脂蛋白(HDL)胆固醇降低是胰岛素抵抗(IR)状态患者(包括糖尿病患者)的关键代谢异常。TG/HDL胆固醇比值被推崇为IR的一项简单临床指标,但研究结果并不一致。总胆固醇/HDL胆固醇比值被广泛用于评估脂质动脉粥样硬化形成,但它在评估IR或其相关冠心病(CHD)风险方面的效用尚不清楚。在3014例患者(平均年龄54岁;55%为女性)中,TG/HDL胆固醇比值和总胆固醇/HDL胆固醇比值与IR(稳态模型评估-IR的最高四分位数)相关。采用逻辑回归构建预测IR的受试者工作特征曲线,以脂质比值作为预测指标。采用多变量Cox回归评估调整脂质比值是否会减弱IR与CHD之间的关联。横断面分析显示,经年龄和性别调整后,IR与TG/HDL胆固醇比值的相关性为0.46,与总胆固醇/HDL胆固醇比值的相关性为0.38。IR患病率随脂质比值三分位数的增加而升高(p<0.0001)。用TG/HDL胆固醇比值预测IR的受试者工作特征曲线下面积为0.745,略高于总胆固醇/HDL胆固醇比值(0.707;比较p<0.001)。在随访期间(平均6.4年),112例患者发生了首次CHD事件。IR与CHD风险相关(多变量调整后的风险比为2.71,95%置信区间为1.79至4.11),即使在调整脂质比值后,该相关性仍具有显著性意义。总之,我们的观察结果表明,TG/HDL胆固醇比值是IR及其相关CHD风险的一个不完美替代指标,在此方面仅略优于总胆固醇/HDL胆固醇比值。